Cargando…
Does BCR-ABL transcript type influence the prognosis of patients in chronic myelogenous leukemia chronic phase?
INTRODUCTION AND OBJECTIVE: In this study, we evaluated the influence of the transcript type on hematological and clinical parameters, as well as the event-free survival of 50 patients in the Chronic myeloid leukemia chronic phase. METHODS: We reviewed the medical records of 55 patients with Chronic...
Autores principales: | de Almeida Filho, T.P., Maia Filho, P.A., Barbosa, Maritza Cavalcante, Dutra, Luana Letícia Alves, Castro, Marilena Facundo de, Duarte, Fernando Barroso, Quixadá, Acy Telles de Souza, Lemes, Romélia Pinheiro Gonçalves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517615/ https://www.ncbi.nlm.nih.gov/pubmed/31079657 http://dx.doi.org/10.1016/j.htct.2018.10.003 |
Ejemplares similares
-
Pancytopenia during tyrosine kinase inhibitor treatment – coexistence of chronic myeloid leukemia and visceral leishmaniasis: a case report
por: Quixada, Acy, et al.
Publicado: (2016) -
Serum concentrations of nitrite and malondialdehyde as markers of oxidative stress in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
por: Petrola, Maria Juracy, et al.
Publicado: (2012) -
Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
por: Ross, Theodora S, et al.
Publicado: (2014) -
Differences in structural elements of Bcr-Abl oncoprotein isoforms in Chronic Myelogenous Leukemia
por: Hai, Abdul, et al.
Publicado: (2014) -
The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia
por: Liu, Yonglan, et al.
Publicado: (2022)